featured
Glutaminase Inhibition Plus Azacitidine for Myelodysplastic Syndromes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses
Nat Cancer 2024 Sep 19;[EPub Ahead of Print], CD DiNardo, D Verma, N Baran, TD Bhagat, A Skwarska, A Lodi, K Saxena, T Cai, X Su, VA Guerra, G Poigaialwar, VM Kuruvilla, S Konoplev, S Gordon-Mitchell, K Pradhan, S Aluri, GL Hackman, S Chaudhry, M Collins, SR Sweeney, J Busquets, AS Rathore, Q Deng, MR Green, S Grant, S Demo, GS Choudhary, S Sahu, B Agarwal, M Spodek, V Thiruthuvanathan, B Will, U Steidl, GD Tippett, J Burger, G Borthakur, E Jabbour, N Pemmaraju, T Kadia, S Kornblau, NG Daver, K Naqvi, NJ Short, G Garcia-Manero, S Tiziani, A Verma, M KonoplevaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.